Forecasting the IBB ETF

Forecasting the XBI ETF

Alpha Bio Strategies

Alpha BioAdvisors integrates fundamental research, with quantitative research innovation, plus advanced technical analyses, to provide a distillation of these perspectives on the biotech segment. We developed a systematic methodology and created an alpha-capture-focused coverage universe.

With a background of recognizing core value in biotech at early stages, Alpha BioAdvisors understands how biotech companies unlock pivotal opportunities that can culminate in realized and recognized value creation. Using proprietary methodologies to examine and evaluate companies, we examine perceived value, recognized value and real asset value to reconcile disconnects with share price/market cap.